Prospera Financial Services’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,754
| Closed | -$287K | – | 1127 |
|
|
2024
Q2 | $287K | Buy |
7,754
+1,932
| +33% | +$71.5K | 0.01% | 936 |
|
|
2024
Q1 | $244K | Buy |
+5,822
| New | +$244K | 0.01% | 976 |
|
|
2022
Q2 | – | Sell |
-2,622
| Closed | -$89K | – | 1772 |
|
|
2022
Q1 | $89K | Buy |
+2,622
| New | +$89K | ﹤0.01% | 1150 |
|
|
2020
Q4 | – | Sell |
-3,738
| Closed | -$55K | – | 823 |
|
|
2020
Q3 | $55K | Buy |
+3,738
| New | +$55K | 0.02% | 584 |
|